COMORBIDITIES IN PULMONARY ARTERIAL HYPERTENSION (PAH): INSIGHTS FROM THE REAL-WORLD OPSUMIT® USERS (OPUS) REGISTRY

Abstract

Many patients with PAH have comorbidities that may exclude them from clinical trials due to stringent inclusion criteria. The OPUS Registry ([NCT02126943][1]) is an ongoing, prospective, multicenter, US drug registry of patients newly treated with macitentan. Here, patient and disease